fda approved semaglutide compound Novo asks to prevent compounders from making GLP-1 knockoffs The FDA Warns of the

Once reconstituted with bacteriostatic water, refrigerate at 28C and use within 2830 days

retatrutide is not it is an investigational compound in published research

Food and Drug Administration prescribing label and safety guidance (official FDA source)

GLP-1 comparison guide: Ozempic vs Wegovy vs Mounjaro vs Zepbound Knowing the differences between these medications is important, but can also be confusing

Retatrutide is an investigational triple agonist peptide (GIP, GLP-1, and glucagon receptor) currently under clinical development for the management of obesity and type 2 diabetes

History of Type 2 Diabetes or Obesity You may also be eligible for GLP-1 treatment if you have a medical history of type 2 diabetes, heart disease, or both